Medindia

X

New Drug Targets for Immune-Mediated Diseases: Pattern Recognition Receptors

by Kathy Jones on  October 16, 2014 at 4:29 PM Research News   - G J E 4
Recent research has shown that chronic inflammation caused by activation of the human immune system contributes to a large and rapidly growing list of diseases.
 New Drug Targets for Immune-Mediated Diseases: Pattern Recognition Receptors
New Drug Targets for Immune-Mediated Diseases: Pattern Recognition Receptors
Advertisement

Significant advances in understanding the role that the cytokine-mediated JAK/STAT signaling network and pattern recognition receptors (PRRs) play in regulating immune responses and their potential as novel targets for developing potent new therapies are presented in a Review article in Journal of Interferon & Cytokine Research (JICR) from Mary Ann Liebert, Inc publishers. The article is available free on the Journal of Interferon & Cytokine Research website until November 15, 2014.

Advertisement
Brendan John Jenkins, MIMR-PHI Institute of Medical Research (Clayton, Victoria, Australia), reviews the latest research and highlights key findings that help explain how cross-talk between cell signaling networks mediated by cytokines and PRRs can impact the development of a variety of disease processes. The authors describe the potential therapeutic implications of targeting these critical networks in the article "Transcriptional Regulation of Pattern Recognition Receptors by JAK/STAT Signaling, and the Implications for Disease Pathogenesis."

"Dr. Jenkins provides an important new perspective on the role of pattern recognition receptors in disease pathogenesis," says JICR Co-Editor-in-Chief Thomas A. Hamilton, PhD, Chairman, Department of Immunology, Cleveland Clinic Foundation, Ohio.



Source: Eurekalert
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All